nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—CYP2D6—Lomustine—hematologic cancer	0.0681	0.189	CbGbCtD
Dexmethylphenidate—CYP2D6—Idarubicin—hematologic cancer	0.0607	0.168	CbGbCtD
Dexmethylphenidate—CYP2D6—Hydroxyurea—hematologic cancer	0.0516	0.143	CbGbCtD
Dexmethylphenidate—CYP2D6—Bortezomib—hematologic cancer	0.0449	0.124	CbGbCtD
Dexmethylphenidate—CYP2D6—Imatinib—hematologic cancer	0.0329	0.0912	CbGbCtD
Dexmethylphenidate—CYP2D6—Nilotinib—hematologic cancer	0.0299	0.0829	CbGbCtD
Dexmethylphenidate—CYP2D6—Vinorelbine—hematologic cancer	0.0296	0.0822	CbGbCtD
Dexmethylphenidate—CYP2D6—Vinblastine—hematologic cancer	0.0183	0.0506	CbGbCtD
Dexmethylphenidate—CYP2D6—Dexamethasone—hematologic cancer	0.0135	0.0375	CbGbCtD
Dexmethylphenidate—CYP2D6—Doxorubicin—hematologic cancer	0.0112	0.0311	CbGbCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000576	0.0115	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Serotonin Transporter Activity—IL1B—hematologic cancer	0.000565	0.0113	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—PER1—hematologic cancer	0.000556	0.0111	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—LCK—hematologic cancer	0.000532	0.0107	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PER3—hematologic cancer	0.000514	0.0103	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000511	0.0102	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.000455	0.00912	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—CASP7—hematologic cancer	0.000446	0.00892	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—SYK—hematologic cancer	0.000439	0.0088	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CRY2—hematologic cancer	0.000437	0.00875	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CRY1—hematologic cancer	0.000437	0.00875	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PER2—hematologic cancer	0.000437	0.00875	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—GATA2—hematologic cancer	0.00042	0.00841	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—ARNTL—hematologic cancer	0.000396	0.00794	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—TSC2—hematologic cancer	0.000385	0.00772	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—CYCS—hematologic cancer	0.000376	0.00753	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—ID3—hematologic cancer	0.000372	0.00744	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—RET—hematologic cancer	0.000371	0.00743	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—MAPK14—hematologic cancer	0.000367	0.00735	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—TSC2—hematologic cancer	0.000331	0.00664	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PER1—hematologic cancer	0.000331	0.00663	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—KMT2A—hematologic cancer	0.000331	0.00663	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—MAPK14—hematologic cancer	0.000316	0.00632	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TOP1—hematologic cancer	0.000303	0.00607	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000301	0.00602	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—ID2—hematologic cancer	0.000295	0.00591	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—TSC2—hematologic cancer	0.000294	0.00588	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—MAPK14—hematologic cancer	0.00028	0.0056	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—ABCC3—hematologic cancer	0.000276	0.00552	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—TXN—hematologic cancer	0.000276	0.00552	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—BAD—hematologic cancer	0.000275	0.0055	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000266	0.00533	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	0.000261	0.00524	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—UGT1A1—hematologic cancer	0.000259	0.00519	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	0.000253	0.00507	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	0.000251	0.00502	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—MAPK14—hematologic cancer	0.000244	0.00488	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—MYB—hematologic cancer	0.000241	0.00483	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—IL1B—hematologic cancer	0.00024	0.00482	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—ABCC3—hematologic cancer	0.000237	0.00475	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—TXN—hematologic cancer	0.000237	0.00475	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—ARNTL—hematologic cancer	0.000236	0.00473	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000232	0.00464	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—UGT1A1—hematologic cancer	0.000223	0.00446	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—ABCC3—hematologic cancer	0.00021	0.00421	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—TXN—hematologic cancer	0.00021	0.00421	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—IL1B—hematologic cancer	0.000207	0.00414	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000207	0.00414	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL13—hematologic cancer	0.000206	0.00413	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000205	0.00411	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—JUND—hematologic cancer	0.000201	0.00402	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—UGT1A1—hematologic cancer	0.000197	0.00395	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—GATA3—hematologic cancer	0.000186	0.00373	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—IL1B—hematologic cancer	0.000183	0.00367	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000183	0.00367	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CST3—hematologic cancer	0.00018	0.00361	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—NQO1—hematologic cancer	0.000178	0.00356	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—TNF—hematologic cancer	0.000175	0.0035	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—FOXO1—hematologic cancer	0.000173	0.00345	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PML—hematologic cancer	0.00017	0.0034	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000167	0.00335	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—HSP90AA1—hematologic cancer	0.000167	0.00334	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—SRC—hematologic cancer	0.000163	0.00327	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Dopaminergic Neurogenesis—STAT3—hematologic cancer	0.000162	0.00324	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—CASP3—hematologic cancer	0.000159	0.00319	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000155	0.00311	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TOP2A—hematologic cancer	0.000155	0.00311	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—NQO1—hematologic cancer	0.000153	0.00306	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—TNF—hematologic cancer	0.00015	0.00301	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Dopaminergic Neurogenesis—TGFB1—hematologic cancer	0.00015	0.003	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000149	0.00299	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—GSTP1—hematologic cancer	0.000148	0.00297	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000148	0.00297	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—AR—hematologic cancer	0.000148	0.00296	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—EZH2—hematologic cancer	0.000147	0.00295	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—HSP90AA1—hematologic cancer	0.000144	0.00288	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—HDAC2—hematologic cancer	0.000139	0.00279	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000138	0.00276	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000137	0.00274	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000137	0.00274	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—HGF—hematologic cancer	0.000136	0.00273	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—GSTM1—hematologic cancer	0.000136	0.00273	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—NQO1—hematologic cancer	0.000135	0.00271	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—SLC35B2—hematologic cancer	0.000134	0.00268	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—TNF—hematologic cancer	0.000133	0.00266	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—EPHX1—hematologic cancer	0.000132	0.00264	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.00013	0.0026	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.000129	0.00259	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000129	0.00258	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—GSTP1—hematologic cancer	0.000127	0.00255	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—HSP90AA1—hematologic cancer	0.000127	0.00255	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000127	0.00254	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000124	0.00249	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000122	0.00244	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000121	0.00242	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.000119	0.00239	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000118	0.00236	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—PDGFB—hematologic cancer	0.000117	0.00235	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—HGF—hematologic cancer	0.000117	0.00234	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—GSTM1—hematologic cancer	0.000117	0.00234	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC22A1—hematologic cancer	0.000114	0.00229	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000114	0.00229	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—GSTP1—hematologic cancer	0.000113	0.00226	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000112	0.00225	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000111	0.00222	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.00011	0.00221	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NCOR1—hematologic cancer	0.000105	0.00211	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000105	0.0021	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—ADCY7—hematologic cancer	0.000105	0.0021	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000104	0.00209	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—HGF—hematologic cancer	0.000104	0.00208	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—GSTM1—hematologic cancer	0.000104	0.00208	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—PDGFB—hematologic cancer	0.000101	0.00202	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PRKCG—hematologic cancer	0.000101	0.00201	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	9.81e-05	0.00197	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	9.6e-05	0.00192	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	9.6e-05	0.00192	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	9.6e-05	0.00192	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—FAS—hematologic cancer	9.45e-05	0.00189	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CAMK2D—hematologic cancer	9.33e-05	0.00187	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	9.3e-05	0.00186	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CREB1—hematologic cancer	9.13e-05	0.00183	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—PDGFB—hematologic cancer	8.92e-05	0.00179	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6R—hematologic cancer	8.9e-05	0.00178	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	8.89e-05	0.00178	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	8.65e-05	0.00173	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTO1—hematologic cancer	8.63e-05	0.00173	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—GSTO1—hematologic cancer	8.51e-05	0.0017	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	8.51e-05	0.0017	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	8.51e-05	0.0017	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SGK1—hematologic cancer	8.51e-05	0.0017	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CDK4—hematologic cancer	8.32e-05	0.00167	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—UGT1A1—hematologic cancer	8.11e-05	0.00162	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—UGT1A1—hematologic cancer	8e-05	0.0016	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—PRKCG—hematologic cancer	7.69e-05	0.00154	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	7.66e-05	0.00153	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	7.59e-05	0.00152	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CREB1—hematologic cancer	7.45e-05	0.00149	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—MTR—hematologic cancer	7.03e-05	0.00141	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	6.94e-05	0.00139	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1B—hematologic cancer	6.77e-05	0.00136	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CASP3—hematologic cancer	6.76e-05	0.00135	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	6.72e-05	0.00135	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTT1—hematologic cancer	6.69e-05	0.00134	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—JUN—hematologic cancer	6.56e-05	0.00131	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	6.55e-05	0.00131	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.36e-05	0.00127	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.32e-05	0.00127	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.19e-05	0.00124	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	6.15e-05	0.00123	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—EP300—hematologic cancer	6.05e-05	0.00121	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—PRKCG—hematologic cancer	5.9e-05	0.00118	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.81e-05	0.00116	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	5.73e-05	0.00115	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.7e-05	0.00114	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.64e-05	0.00113	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.63e-05	0.00113	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.6e-05	0.00112	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—TGFB1—hematologic cancer	5.55e-05	0.00111	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.52e-05	0.0011	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.48e-05	0.0011	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—JUN—hematologic cancer	5.36e-05	0.00107	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PTEN—hematologic cancer	5.18e-05	0.00104	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—MAPK8—hematologic cancer	5.07e-05	0.00102	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—EP300—hematologic cancer	4.94e-05	0.00099	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—hematologic cancer	4.91e-05	0.000984	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.89e-05	0.000979	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—TGFB1—hematologic cancer	4.77e-05	0.000956	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.75e-05	0.000952	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.71e-05	0.000944	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	4.64e-05	0.000929	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.63e-05	0.000927	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	4.57e-05	0.000916	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CREB1—hematologic cancer	4.37e-05	0.000874	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—BRAF—hematologic cancer	4.31e-05	0.000864	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	4.26e-05	0.000853	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—TGFB1—hematologic cancer	4.23e-05	0.000847	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.21e-05	0.000844	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	4.2e-05	0.000842	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.1e-05	0.000821	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.97e-05	0.000794	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.86e-05	0.000774	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—MDM2—hematologic cancer	3.61e-05	0.000724	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PHYH—hematologic cancer	3.55e-05	0.000712	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GMPS—hematologic cancer	3.55e-05	0.000712	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—FTCD—hematologic cancer	3.55e-05	0.000712	CbGpPWpGaD
Dexmethylphenidate—Eye disorder—Doxorubicin—hematologic cancer	3.54e-05	6e-05	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TP53—hematologic cancer	3.54e-05	0.000708	CbGpPWpGaD
Dexmethylphenidate—Ill-defined disorder—Methotrexate—hematologic cancer	3.53e-05	5.99e-05	CcSEcCtD
Dexmethylphenidate—Anaemia—Methotrexate—hematologic cancer	3.52e-05	5.97e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Betamethasone—hematologic cancer	3.52e-05	5.97e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Dexamethasone—hematologic cancer	3.52e-05	5.97e-05	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Doxorubicin—hematologic cancer	3.51e-05	5.96e-05	CcSEcCtD
Dexmethylphenidate—Flushing—Doxorubicin—hematologic cancer	3.51e-05	5.96e-05	CcSEcCtD
Dexmethylphenidate—Tension—Epirubicin—hematologic cancer	3.5e-05	5.93e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.49e-05	5.92e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Betamethasone—hematologic cancer	3.49e-05	5.92e-05	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Triamcinolone—hematologic cancer	3.47e-05	5.88e-05	CcSEcCtD
Dexmethylphenidate—Nervousness—Epirubicin—hematologic cancer	3.46e-05	5.87e-05	CcSEcCtD
Dexmethylphenidate—Back pain—Epirubicin—hematologic cancer	3.45e-05	5.85e-05	CcSEcCtD
Dexmethylphenidate—Angiopathy—Doxorubicin—hematologic cancer	3.43e-05	5.83e-05	CcSEcCtD
Dexmethylphenidate—Malaise—Methotrexate—hematologic cancer	3.43e-05	5.83e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Etoposide—hematologic cancer	3.43e-05	5.82e-05	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Epirubicin—hematologic cancer	3.42e-05	5.81e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.42e-05	0.000685	CbGpPWpGaD
Dexmethylphenidate—Immune system disorder—Doxorubicin—hematologic cancer	3.42e-05	5.8e-05	CcSEcCtD
Dexmethylphenidate—Vertigo—Methotrexate—hematologic cancer	3.42e-05	5.8e-05	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Doxorubicin—hematologic cancer	3.41e-05	5.79e-05	CcSEcCtD
Dexmethylphenidate—Leukopenia—Methotrexate—hematologic cancer	3.41e-05	5.78e-05	CcSEcCtD
Dexmethylphenidate—Chills—Doxorubicin—hematologic cancer	3.4e-05	5.77e-05	CcSEcCtD
Dexmethylphenidate—Urticaria—Betamethasone—hematologic cancer	3.39e-05	5.75e-05	CcSEcCtD
Dexmethylphenidate—Urticaria—Dexamethasone—hematologic cancer	3.39e-05	5.75e-05	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.39e-05	5.75e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Prednisolone—hematologic cancer	3.38e-05	5.74e-05	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Doxorubicin—hematologic cancer	3.38e-05	5.74e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Triamcinolone—hematologic cancer	3.37e-05	5.73e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Dexamethasone—hematologic cancer	3.37e-05	5.73e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Dexamethasone—hematologic cancer	3.37e-05	5.73e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Betamethasone—hematologic cancer	3.37e-05	5.73e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Betamethasone—hematologic cancer	3.37e-05	5.73e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Cisplatin—hematologic cancer	3.36e-05	5.71e-05	CcSEcCtD
Dexmethylphenidate—Insomnia—Prednisone—hematologic cancer	3.36e-05	5.71e-05	CcSEcCtD
Dexmethylphenidate—Vision blurred—Epirubicin—hematologic cancer	3.36e-05	5.7e-05	CcSEcCtD
Dexmethylphenidate—Alopecia—Doxorubicin—hematologic cancer	3.35e-05	5.68e-05	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Prednisone—hematologic cancer	3.34e-05	5.66e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Triamcinolone—hematologic cancer	3.33e-05	5.65e-05	CcSEcCtD
Dexmethylphenidate—Cough—Methotrexate—hematologic cancer	3.32e-05	5.64e-05	CcSEcCtD
Dexmethylphenidate—Mental disorder—Doxorubicin—hematologic cancer	3.32e-05	5.63e-05	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Epirubicin—hematologic cancer	3.3e-05	5.61e-05	CcSEcCtD
Dexmethylphenidate—Convulsion—Methotrexate—hematologic cancer	3.3e-05	5.6e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Etoposide—hematologic cancer	3.3e-05	5.6e-05	CcSEcCtD
Dexmethylphenidate—Erythema—Doxorubicin—hematologic cancer	3.3e-05	5.59e-05	CcSEcCtD
Dexmethylphenidate—Malnutrition—Doxorubicin—hematologic cancer	3.3e-05	5.59e-05	CcSEcCtD
Dexmethylphenidate—Anaemia—Epirubicin—hematologic cancer	3.29e-05	5.59e-05	CcSEcCtD
Dexmethylphenidate—Agitation—Epirubicin—hematologic cancer	3.27e-05	5.56e-05	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Prednisone—hematologic cancer	3.27e-05	5.55e-05	CcSEcCtD
Dexmethylphenidate—Rash—Etoposide—hematologic cancer	3.27e-05	5.55e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Etoposide—hematologic cancer	3.27e-05	5.54e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—SMPD3—hematologic cancer	3.25e-05	0.000651	CbGpPWpGaD
Dexmethylphenidate—Headache—Etoposide—hematologic cancer	3.25e-05	5.51e-05	CcSEcCtD
Dexmethylphenidate—Arthralgia—Methotrexate—hematologic cancer	3.24e-05	5.5e-05	CcSEcCtD
Dexmethylphenidate—Chest pain—Methotrexate—hematologic cancer	3.24e-05	5.5e-05	CcSEcCtD
Dexmethylphenidate—Myalgia—Methotrexate—hematologic cancer	3.24e-05	5.5e-05	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—IL6—hematologic cancer	3.24e-05	0.000648	CbGpPWpGaD
Dexmethylphenidate—Tension—Doxorubicin—hematologic cancer	3.23e-05	5.49e-05	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Prednisone—hematologic cancer	3.23e-05	5.48e-05	CcSEcCtD
Dexmethylphenidate—Rash—Prednisolone—hematologic cancer	3.23e-05	5.47e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Prednisolone—hematologic cancer	3.22e-05	5.47e-05	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.22e-05	5.46e-05	CcSEcCtD
Dexmethylphenidate—Malaise—Epirubicin—hematologic cancer	3.21e-05	5.45e-05	CcSEcCtD
Dexmethylphenidate—Fatigue—Prednisone—hematologic cancer	3.2e-05	5.44e-05	CcSEcCtD
Dexmethylphenidate—Headache—Prednisolone—hematologic cancer	3.2e-05	5.44e-05	CcSEcCtD
Dexmethylphenidate—Discomfort—Methotrexate—hematologic cancer	3.2e-05	5.43e-05	CcSEcCtD
Dexmethylphenidate—Nervousness—Doxorubicin—hematologic cancer	3.2e-05	5.43e-05	CcSEcCtD
Dexmethylphenidate—Vertigo—Epirubicin—hematologic cancer	3.2e-05	5.43e-05	CcSEcCtD
Dexmethylphenidate—Syncope—Epirubicin—hematologic cancer	3.19e-05	5.42e-05	CcSEcCtD
Dexmethylphenidate—Leukopenia—Epirubicin—hematologic cancer	3.19e-05	5.41e-05	CcSEcCtD
Dexmethylphenidate—Back pain—Doxorubicin—hematologic cancer	3.19e-05	5.41e-05	CcSEcCtD
Dexmethylphenidate—Constipation—Prednisone—hematologic cancer	3.18e-05	5.39e-05	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Doxorubicin—hematologic cancer	3.17e-05	5.38e-05	CcSEcCtD
Dexmethylphenidate—Palpitations—Epirubicin—hematologic cancer	3.15e-05	5.34e-05	CcSEcCtD
Dexmethylphenidate—Confusional state—Methotrexate—hematologic cancer	3.13e-05	5.32e-05	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Epirubicin—hematologic cancer	3.13e-05	5.31e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Triamcinolone—hematologic cancer	3.11e-05	5.28e-05	CcSEcCtD
Dexmethylphenidate—Cough—Epirubicin—hematologic cancer	3.11e-05	5.28e-05	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Methotrexate—hematologic cancer	3.11e-05	5.27e-05	CcSEcCtD
Dexmethylphenidate—Vision blurred—Doxorubicin—hematologic cancer	3.11e-05	5.27e-05	CcSEcCtD
Dexmethylphenidate—Convulsion—Epirubicin—hematologic cancer	3.09e-05	5.24e-05	CcSEcCtD
Dexmethylphenidate—Infection—Methotrexate—hematologic cancer	3.09e-05	5.24e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Etoposide—hematologic cancer	3.08e-05	5.23e-05	CcSEcCtD
Dexmethylphenidate—Hypertension—Epirubicin—hematologic cancer	3.08e-05	5.22e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Prednisone—hematologic cancer	3.06e-05	5.2e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Betamethasone—hematologic cancer	3.06e-05	5.2e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Dexamethasone—hematologic cancer	3.06e-05	5.2e-05	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Doxorubicin—hematologic cancer	3.06e-05	5.19e-05	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Methotrexate—hematologic cancer	3.05e-05	5.17e-05	CcSEcCtD
Dexmethylphenidate—Anaemia—Doxorubicin—hematologic cancer	3.05e-05	5.17e-05	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Methotrexate—hematologic cancer	3.04e-05	5.16e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Prednisone—hematologic cancer	3.04e-05	5.16e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Prednisolone—hematologic cancer	3.04e-05	5.16e-05	CcSEcCtD
Dexmethylphenidate—Arthralgia—Epirubicin—hematologic cancer	3.03e-05	5.15e-05	CcSEcCtD
Dexmethylphenidate—Chest pain—Epirubicin—hematologic cancer	3.03e-05	5.15e-05	CcSEcCtD
Dexmethylphenidate—Myalgia—Epirubicin—hematologic cancer	3.03e-05	5.15e-05	CcSEcCtD
Dexmethylphenidate—Agitation—Doxorubicin—hematologic cancer	3.03e-05	5.14e-05	CcSEcCtD
Dexmethylphenidate—Anxiety—Epirubicin—hematologic cancer	3.02e-05	5.13e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Betamethasone—hematologic cancer	3.02e-05	5.12e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Dexamethasone—hematologic cancer	3.02e-05	5.12e-05	CcSEcCtD
Dexmethylphenidate—Skin disorder—Methotrexate—hematologic cancer	3.02e-05	5.12e-05	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.01e-05	5.11e-05	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Methotrexate—hematologic cancer	3e-05	5.1e-05	CcSEcCtD
Dexmethylphenidate—Discomfort—Epirubicin—hematologic cancer	3e-05	5.08e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Triamcinolone—hematologic cancer	2.99e-05	5.08e-05	CcSEcCtD
Dexmethylphenidate—Malaise—Doxorubicin—hematologic cancer	2.97e-05	5.04e-05	CcSEcCtD
Dexmethylphenidate—Rash—Triamcinolone—hematologic cancer	2.97e-05	5.03e-05	CcSEcCtD
Dexmethylphenidate—Dry mouth—Epirubicin—hematologic cancer	2.97e-05	5.03e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Triamcinolone—hematologic cancer	2.96e-05	5.03e-05	CcSEcCtD
Dexmethylphenidate—Vertigo—Doxorubicin—hematologic cancer	2.96e-05	5.03e-05	CcSEcCtD
Dexmethylphenidate—Anorexia—Methotrexate—hematologic cancer	2.96e-05	5.03e-05	CcSEcCtD
Dexmethylphenidate—Syncope—Doxorubicin—hematologic cancer	2.96e-05	5.02e-05	CcSEcCtD
Dexmethylphenidate—Urticaria—Prednisone—hematologic cancer	2.95e-05	5.01e-05	CcSEcCtD
Dexmethylphenidate—Leukopenia—Doxorubicin—hematologic cancer	2.95e-05	5.01e-05	CcSEcCtD
Dexmethylphenidate—Headache—Triamcinolone—hematologic cancer	2.95e-05	5e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Prednisone—hematologic cancer	2.94e-05	4.99e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Prednisone—hematologic cancer	2.94e-05	4.99e-05	CcSEcCtD
Dexmethylphenidate—Confusional state—Epirubicin—hematologic cancer	2.93e-05	4.97e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Betamethasone—hematologic cancer	2.92e-05	4.96e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Dexamethasone—hematologic cancer	2.92e-05	4.96e-05	CcSEcCtD
Dexmethylphenidate—Palpitations—Doxorubicin—hematologic cancer	2.91e-05	4.94e-05	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Epirubicin—hematologic cancer	2.91e-05	4.93e-05	CcSEcCtD
Dexmethylphenidate—Oedema—Epirubicin—hematologic cancer	2.91e-05	4.93e-05	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Doxorubicin—hematologic cancer	2.9e-05	4.92e-05	CcSEcCtD
Dexmethylphenidate—Infection—Epirubicin—hematologic cancer	2.89e-05	4.9e-05	CcSEcCtD
Dexmethylphenidate—Cough—Doxorubicin—hematologic cancer	2.88e-05	4.88e-05	CcSEcCtD
Dexmethylphenidate—Shock—Epirubicin—hematologic cancer	2.86e-05	4.85e-05	CcSEcCtD
Dexmethylphenidate—Convulsion—Doxorubicin—hematologic cancer	2.86e-05	4.85e-05	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Epirubicin—hematologic cancer	2.85e-05	4.84e-05	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Epirubicin—hematologic cancer	2.85e-05	4.83e-05	CcSEcCtD
Dexmethylphenidate—Hypertension—Doxorubicin—hematologic cancer	2.85e-05	4.83e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—DCK—hematologic cancer	2.84e-05	0.000569	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ASNS—hematologic cancer	2.84e-05	0.000569	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—B3GAT1—hematologic cancer	2.84e-05	0.000569	CbGpPWpGaD
Dexmethylphenidate—Tachycardia—Epirubicin—hematologic cancer	2.84e-05	4.82e-05	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.83e-05	4.8e-05	CcSEcCtD
Dexmethylphenidate—Skin disorder—Epirubicin—hematologic cancer	2.82e-05	4.79e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Betamethasone—hematologic cancer	2.82e-05	4.79e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Dexamethasone—hematologic cancer	2.82e-05	4.79e-05	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Epirubicin—hematologic cancer	2.81e-05	4.77e-05	CcSEcCtD
Dexmethylphenidate—Insomnia—Methotrexate—hematologic cancer	2.81e-05	4.77e-05	CcSEcCtD
Dexmethylphenidate—Arthralgia—Doxorubicin—hematologic cancer	2.81e-05	4.76e-05	CcSEcCtD
Dexmethylphenidate—Myalgia—Doxorubicin—hematologic cancer	2.81e-05	4.76e-05	CcSEcCtD
Dexmethylphenidate—Chest pain—Doxorubicin—hematologic cancer	2.81e-05	4.76e-05	CcSEcCtD
Dexmethylphenidate—Anxiety—Doxorubicin—hematologic cancer	2.8e-05	4.75e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Triamcinolone—hematologic cancer	2.79e-05	4.74e-05	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Methotrexate—hematologic cancer	2.79e-05	4.73e-05	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.79e-05	4.73e-05	CcSEcCtD
Dexmethylphenidate—Discomfort—Doxorubicin—hematologic cancer	2.77e-05	4.7e-05	CcSEcCtD
Dexmethylphenidate—Anorexia—Epirubicin—hematologic cancer	2.77e-05	4.7e-05	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Methotrexate—hematologic cancer	2.77e-05	4.7e-05	CcSEcCtD
Dexmethylphenidate—Somnolence—Methotrexate—hematologic cancer	2.76e-05	4.69e-05	CcSEcCtD
Dexmethylphenidate—Dry mouth—Doxorubicin—hematologic cancer	2.74e-05	4.66e-05	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Prednisone—hematologic cancer	2.74e-05	4.65e-05	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Methotrexate—hematologic cancer	2.73e-05	4.64e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Betamethasone—hematologic cancer	2.71e-05	4.61e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Dexamethasone—hematologic cancer	2.71e-05	4.61e-05	CcSEcCtD
Dexmethylphenidate—Confusional state—Doxorubicin—hematologic cancer	2.71e-05	4.6e-05	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Methotrexate—hematologic cancer	2.7e-05	4.58e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—HDC—hematologic cancer	2.69e-05	0.000539	CbGpPWpGaD
Dexmethylphenidate—Rash—Betamethasone—hematologic cancer	2.69e-05	4.57e-05	CcSEcCtD
Dexmethylphenidate—Rash—Dexamethasone—hematologic cancer	2.69e-05	4.57e-05	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Doxorubicin—hematologic cancer	2.69e-05	4.56e-05	CcSEcCtD
Dexmethylphenidate—Oedema—Doxorubicin—hematologic cancer	2.69e-05	4.56e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Betamethasone—hematologic cancer	2.69e-05	4.56e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Dexamethasone—hematologic cancer	2.69e-05	4.56e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.68e-05	4.55e-05	CcSEcCtD
Dexmethylphenidate—Fatigue—Methotrexate—hematologic cancer	2.68e-05	4.55e-05	CcSEcCtD
Dexmethylphenidate—Headache—Dexamethasone—hematologic cancer	2.67e-05	4.54e-05	CcSEcCtD
Dexmethylphenidate—Headache—Betamethasone—hematologic cancer	2.67e-05	4.54e-05	CcSEcCtD
Dexmethylphenidate—Infection—Doxorubicin—hematologic cancer	2.67e-05	4.54e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Prednisone—hematologic cancer	2.67e-05	4.53e-05	CcSEcCtD
Dexmethylphenidate—Pain—Methotrexate—hematologic cancer	2.66e-05	4.51e-05	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.65e-05	4.49e-05	CcSEcCtD
Dexmethylphenidate—Shock—Doxorubicin—hematologic cancer	2.65e-05	4.49e-05	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Doxorubicin—hematologic cancer	2.64e-05	4.48e-05	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Doxorubicin—hematologic cancer	2.63e-05	4.47e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Prednisone—hematologic cancer	2.63e-05	4.46e-05	CcSEcCtD
Dexmethylphenidate—Insomnia—Epirubicin—hematologic cancer	2.63e-05	4.46e-05	CcSEcCtD
Dexmethylphenidate—Tachycardia—Doxorubicin—hematologic cancer	2.63e-05	4.46e-05	CcSEcCtD
Dexmethylphenidate—Skin disorder—Doxorubicin—hematologic cancer	2.61e-05	4.43e-05	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Epirubicin—hematologic cancer	2.61e-05	4.43e-05	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Doxorubicin—hematologic cancer	2.6e-05	4.41e-05	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Epirubicin—hematologic cancer	2.59e-05	4.4e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.59e-05	0.000518	CbGpPWpGaD
Dexmethylphenidate—Somnolence—Epirubicin—hematologic cancer	2.58e-05	4.39e-05	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.58e-05	0.000517	CbGpPWpGaD
Dexmethylphenidate—Anorexia—Doxorubicin—hematologic cancer	2.56e-05	4.35e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Methotrexate—hematologic cancer	2.56e-05	4.34e-05	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Epirubicin—hematologic cancer	2.56e-05	4.34e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Prednisone—hematologic cancer	2.54e-05	4.32e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Methotrexate—hematologic cancer	2.54e-05	4.31e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Dexamethasone—hematologic cancer	2.54e-05	4.3e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Betamethasone—hematologic cancer	2.54e-05	4.3e-05	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Epirubicin—hematologic cancer	2.53e-05	4.29e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.51e-05	4.26e-05	CcSEcCtD
Dexmethylphenidate—Fatigue—Epirubicin—hematologic cancer	2.51e-05	4.25e-05	CcSEcCtD
Dexmethylphenidate—Pain—Epirubicin—hematologic cancer	2.49e-05	4.22e-05	CcSEcCtD
Dexmethylphenidate—Constipation—Epirubicin—hematologic cancer	2.49e-05	4.22e-05	CcSEcCtD
Dexmethylphenidate—Urticaria—Methotrexate—hematologic cancer	2.47e-05	4.19e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—CDA—hematologic cancer	2.46e-05	0.000493	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Prednisone—hematologic cancer	2.46e-05	4.17e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Methotrexate—hematologic cancer	2.46e-05	4.17e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Methotrexate—hematologic cancer	2.46e-05	4.17e-05	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.45e-05	4.16e-05	CcSEcCtD
Dexmethylphenidate—Insomnia—Doxorubicin—hematologic cancer	2.43e-05	4.13e-05	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.42e-05	0.000484	CbGpPWpGaD
Dexmethylphenidate—Paraesthesia—Doxorubicin—hematologic cancer	2.42e-05	4.1e-05	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Doxorubicin—hematologic cancer	2.4e-05	4.07e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Epirubicin—hematologic cancer	2.4e-05	4.07e-05	CcSEcCtD
Dexmethylphenidate—Somnolence—Doxorubicin—hematologic cancer	2.39e-05	4.06e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Epirubicin—hematologic cancer	2.38e-05	4.03e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—PC—hematologic cancer	2.37e-05	0.000475	CbGpPWpGaD
Dexmethylphenidate—Dyspepsia—Doxorubicin—hematologic cancer	2.37e-05	4.02e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Prednisone—hematologic cancer	2.36e-05	4.01e-05	CcSEcCtD
Dexmethylphenidate—Rash—Prednisone—hematologic cancer	2.34e-05	3.98e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Prednisone—hematologic cancer	2.34e-05	3.97e-05	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Doxorubicin—hematologic cancer	2.34e-05	3.97e-05	CcSEcCtD
Dexmethylphenidate—Headache—Prednisone—hematologic cancer	2.33e-05	3.95e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.32e-05	3.94e-05	CcSEcCtD
Dexmethylphenidate—Fatigue—Doxorubicin—hematologic cancer	2.32e-05	3.94e-05	CcSEcCtD
Dexmethylphenidate—Urticaria—Epirubicin—hematologic cancer	2.31e-05	3.92e-05	CcSEcCtD
Dexmethylphenidate—Constipation—Doxorubicin—hematologic cancer	2.3e-05	3.9e-05	CcSEcCtD
Dexmethylphenidate—Pain—Doxorubicin—hematologic cancer	2.3e-05	3.9e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Epirubicin—hematologic cancer	2.3e-05	3.9e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Epirubicin—hematologic cancer	2.3e-05	3.9e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—SLC35B2—hematologic cancer	2.29e-05	0.000459	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GBA—hematologic cancer	2.29e-05	0.000459	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Methotrexate—hematologic cancer	2.29e-05	3.88e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.29e-05	0.000458	CbGpPWpGaD
Dexmethylphenidate—Asthenia—Methotrexate—hematologic cancer	2.23e-05	3.78e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Doxorubicin—hematologic cancer	2.22e-05	3.76e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Prednisone—hematologic cancer	2.21e-05	3.75e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.2e-05	3.73e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Methotrexate—hematologic cancer	2.2e-05	3.73e-05	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Epirubicin—hematologic cancer	2.14e-05	3.63e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.14e-05	0.000429	CbGpPWpGaD
Dexmethylphenidate—Urticaria—Doxorubicin—hematologic cancer	2.14e-05	3.63e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Doxorubicin—hematologic cancer	2.13e-05	3.61e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Doxorubicin—hematologic cancer	2.13e-05	3.61e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Methotrexate—hematologic cancer	2.13e-05	3.61e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—MTAP—hematologic cancer	2.09e-05	0.000419	CbGpPWpGaD
Dexmethylphenidate—Asthenia—Epirubicin—hematologic cancer	2.09e-05	3.54e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Epirubicin—hematologic cancer	2.06e-05	3.49e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Methotrexate—hematologic cancer	2.05e-05	3.49e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Epirubicin—hematologic cancer	1.99e-05	3.38e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Neuronal System—HRAS—hematologic cancer	1.98e-05	0.000397	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Doxorubicin—hematologic cancer	1.98e-05	3.36e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Methotrexate—hematologic cancer	1.98e-05	3.35e-05	CcSEcCtD
Dexmethylphenidate—Rash—Methotrexate—hematologic cancer	1.96e-05	3.32e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Methotrexate—hematologic cancer	1.96e-05	3.32e-05	CcSEcCtD
Dexmethylphenidate—Headache—Methotrexate—hematologic cancer	1.95e-05	3.3e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Doxorubicin—hematologic cancer	1.93e-05	3.28e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Epirubicin—hematologic cancer	1.92e-05	3.26e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Doxorubicin—hematologic cancer	1.9e-05	3.23e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—FHL2—hematologic cancer	1.87e-05	0.000374	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Epirubicin—hematologic cancer	1.85e-05	3.14e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Methotrexate—hematologic cancer	1.85e-05	3.13e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Doxorubicin—hematologic cancer	1.84e-05	3.12e-05	CcSEcCtD
Dexmethylphenidate—Rash—Epirubicin—hematologic cancer	1.83e-05	3.11e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Epirubicin—hematologic cancer	1.83e-05	3.11e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—AGRN—hematologic cancer	1.83e-05	0.000367	CbGpPWpGaD
Dexmethylphenidate—Headache—Epirubicin—hematologic cancer	1.82e-05	3.09e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Doxorubicin—hematologic cancer	1.78e-05	3.02e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—IDH2—hematologic cancer	1.74e-05	0.000348	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HMMR—hematologic cancer	1.74e-05	0.000348	CbGpPWpGaD
Dexmethylphenidate—Nausea—Epirubicin—hematologic cancer	1.73e-05	2.93e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Doxorubicin—hematologic cancer	1.71e-05	2.9e-05	CcSEcCtD
Dexmethylphenidate—Rash—Doxorubicin—hematologic cancer	1.7e-05	2.88e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Doxorubicin—hematologic cancer	1.69e-05	2.88e-05	CcSEcCtD
Dexmethylphenidate—Headache—Doxorubicin—hematologic cancer	1.69e-05	2.86e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.63e-05	0.000327	CbGpPWpGaD
Dexmethylphenidate—Nausea—Doxorubicin—hematologic cancer	1.6e-05	2.71e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—CA9—hematologic cancer	1.59e-05	0.000318	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ACP5—hematologic cancer	1.59e-05	0.000318	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.57e-05	0.000314	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—IDH1—hematologic cancer	1.49e-05	0.000299	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.48e-05	0.000295	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.48e-05	0.000295	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—TXN—hematologic cancer	1.48e-05	0.000295	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.44e-05	0.000289	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.39e-05	0.000278	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.35e-05	0.00027	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.35e-05	0.00027	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.32e-05	0.000263	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NUP98—hematologic cancer	1.27e-05	0.000255	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.24e-05	0.000248	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.24e-05	0.000248	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NUP214—hematologic cancer	1.23e-05	0.000246	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—MTR—hematologic cancer	1.2e-05	0.000241	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.2e-05	0.000241	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ENO2—hematologic cancer	1.18e-05	0.000236	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.14e-05	0.000229	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SDC1—hematologic cancer	1.12e-05	0.000224	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NQO1—hematologic cancer	9.51e-06	0.00019	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CD44—hematologic cancer	9.51e-06	0.00019	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYCS—hematologic cancer	9e-06	0.00018	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	8.94e-06	0.000179	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTP1—hematologic cancer	7.93e-06	0.000159	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCB1—hematologic cancer	7.51e-06	0.00015	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NCOR1—hematologic cancer	7.29e-06	0.000146	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTM1—hematologic cancer	7.29e-06	0.000146	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—MTHFR—hematologic cancer	6.44e-06	0.000129	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CG—hematologic cancer	5.41e-06	0.000108	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.02e-06	0.0001	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.76e-06	9.53e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALB—hematologic cancer	4.7e-06	9.4e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.49e-06	9e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.15e-06	8.3e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTEN—hematologic cancer	3.58e-06	7.18e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—EP300—hematologic cancer	3.42e-06	6.84e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.53e-06	5.06e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AKT1—hematologic cancer	2.06e-06	4.14e-05	CbGpPWpGaD
